‘Next generation’ chromium shows superior insulin management
date:Jun 13, 2012
Three months of supplementation with 400 micrograms of elemental chromium in the form of chromium dinicocysteinate produced 30% improvements in reduced fasting insulin levels and insulin resistance, compared with no significant improvements in the placebo or chromium picolinate.

Results of this study indicate that the presence of the cysteinate molecule in chromium dinicocysteinate helps provide better protection against the oxidative stress and the activation of signal transduction pathways as
1/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/16 12:43